Formosa Pharmaceuticals signs licensing deal with Arrotex for APP13007 in Australia and New Zealand
Merck and Mayo Clinic launch AI-driven drug discovery collaboration
Palisade Bio makes Clinical Advisory Board appointment
STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)
Hoth Therapeutics granted US patent for novel exon-skipping therapy targeting allergic diseases
DifGen Pharmaceuticals' Fluorometholone Ophthalmic Suspension, 0.1% receives FDA approval
Devonian reports gene expression data showing Thykamine's molecular effects in MASH model
Arctic Therapeutics enrols first patients in Phase IIa trial of AT-004 for acne vulgaris
Formation Bio acquires worldwide rights to FHND5032 from CTFH
Almirall receives China approval for Seysara to treat moderate-to-severe acne
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Physiomics secures new modelling contract with Numab Therapeutics
Simcere Pharmaceutical enter licence and collaboration agreement with Boehringer Ingelheim